Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1981 1
1982 5
1983 5
1984 3
1990 1
1993 1
1998 1
1999 1
2001 1
2002 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
Bluefarb SM, Howard FM, Leibsohn E, Schlagel CA, Wexler L. Bluefarb SM, et al. J Int Med Res. 1976;4(6):454-61. doi: 10.1177/030006057600400613. J Int Med Res. 1976. PMID: 800385 Clinical Trial.
Diflorasone diacetate, a new topical corticosteroid, was generally more potent than three high potency reference standards (fluocinonide, beta-methasone 17-valerate and fluocinolone acetonide) when the compounds were dissolved in 95% alcohol and applied in vasoconstrictor …
Diflorasone diacetate, a new topical corticosteroid, was generally more potent than three high potency reference standards (fluocinon …
A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy.
Kaidbey K, Kopper SC, Sefton J, Gibson JR. Kaidbey K, et al. Int J Dermatol. 2001 Jul;40(7):468-71. doi: 10.1046/j.1365-4362.2001.01234.x. Int J Dermatol. 2001. PMID: 11679006 Clinical Trial.
METHODS: Each of 24 healthy volunteers received the following six treatments (applied 6 days per week for 4 weeks), which were randomized to each of six sites on their forearms: no treatment, tazarotene vehicle, tazarotene vehicle + tazarotene gel 0.1%, diflorasone diaceta …
METHODS: Each of 24 healthy volunteers received the following six treatments (applied 6 days per week for 4 weeks), which were randomized to …
Comparative efficacy of once a day diflorasone diacetate and twice a day betamethasone valerate ointment applications in eczematous dermatitis.
Johansson EA, Stiger TR. Johansson EA, et al. Curr Med Res Opin. 1984;9(4):259-64. doi: 10.1185/03007998409109589. Curr Med Res Opin. 1984. PMID: 6510015 Clinical Trial.
Altogether 32 patients completed the 3-week study. Fourteen patients in the diflorasone group and 6 on betamethasone left the study earlier because of total (100%) improvement of lesions. ...At Week 3, this difference in the improvement of pruritus was marginally significa …
Altogether 32 patients completed the 3-week study. Fourteen patients in the diflorasone group and 6 on betamethasone left the study e …
A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.
Green L, Sadoff W. Green L, et al. J Cutan Med Surg. 2002 Mar-Apr;6(2):95-102. doi: 10.1007/s10227-001-0031-z. Epub 2002 Feb 13. J Cutan Med Surg. 2002. PMID: 11992180 Clinical Trial.
METHODS: A 12-week, multicenter, investigator-masked, randomized, parallel-group study was performed with more than 200 patients who were randomly assigned to regimens of tazarotene 0.1% gel alone, tazarotene plus a high-potency topical corticosteroid (fluocinonide 0.05% ointment …
METHODS: A 12-week, multicenter, investigator-masked, randomized, parallel-group study was performed with more than 200 patients who were ra …
Comparative efficacy of once-daily flurandrenolide tape versus twice-daily diflorasone diacetate ointment in the treatment of psoriasis.
Krueger GG, O'Reilly MA, Weidner M, Dromgoole SH, Killey FP. Krueger GG, et al. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):186-90. doi: 10.1016/s0190-9622(98)70238-5. J Am Acad Dermatol. 1998. PMID: 9486672 Clinical Trial.
OBJECTIVE: Our purpose was to determine the relative efficacy of flurandrenolide (4 microg/cm2) tape versus 0.05% diflorasone diacetate ointment in plaque psoriasis. METHODS: Thirty patients participated in an investigator-blinded, randomized, bilateral paired-comparison s …
OBJECTIVE: Our purpose was to determine the relative efficacy of flurandrenolide (4 microg/cm2) tape versus 0.05% diflorasone diaceta …
Comparison of diflorasone diacetate and betamethasone dipropionate ointment in the treatment of psoriasis.
Leibsohn E. Leibsohn E. J Int Med Res. 1982;10(1):22-7. doi: 10.1177/030006058201000104. J Int Med Res. 1982. PMID: 7073809 Clinical Trial.
In this double-blind study, 100 patients with mild, moderate, or severe thick lesion psoriasis, characterized as acute, subacute, or chronic, were treated with either diflorasone diacetate ointment 0.05% or betamethasone dipropionate ointment 0.05% twice a day for 3 weeks. …
In this double-blind study, 100 patients with mild, moderate, or severe thick lesion psoriasis, characterized as acute, subacute, or chronic …
Adrenal suppression with high-potency corticosteroid ointment formulations in normal subjects.
Novak E, Francom SF, Schlagel CA. Novak E, et al. Clin Ther. 1983;6(1):59-71. Clin Ther. 1983. PMID: 6370438 Clinical Trial.
In this 14-day, double-blind, in-clinic study, 24 healthy male volunteers were assigned at random to one of four treatment groups to compare the effects of a new formulation of 0.05% diflorasone diacetate ointment in a vehicle of propylene glycol (PG) with the effects of o …
In this 14-day, double-blind, in-clinic study, 24 healthy male volunteers were assigned at random to one of four treatment groups to compare …
Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
Shupack JL, Jondreau L, Kenny C, Stiller MJ. Shupack JL, et al. Dermatology. 1993;186(2):129-32. doi: 10.1159/000247323. Dermatology. 1993. PMID: 8428041 Clinical Trial.
We report the results of a 2-week double-blind, parallel clinical trial comparing two superpotent topical glucocorticosteroid ointments, diflorasone diacetate 0.05% and betamethasone dipropionate 0.05%, in psoriatic adults. ...
We report the results of a 2-week double-blind, parallel clinical trial comparing two superpotent topical glucocorticosteroid ointments, …
Once-daily treatment of psoriasis with topical glucocorticosteroid ointments.
Lane AT, Wachs GN, Weston WL. Lane AT, et al. J Am Acad Dermatol. 1983 Apr;8(4):523-5. doi: 10.1016/s0190-9622(83)70059-9. J Am Acad Dermatol. 1983. PMID: 6853785 Clinical Trial.
After 3 weeks of once-daily therapy, psoriasis subjects treated with betamethasone dipropionate (BD) ointment or diflorasone diacetate (DD) ointment showed statistically significant (p less than 0.01) improvement compared to subjects using vehicle alone....
After 3 weeks of once-daily therapy, psoriasis subjects treated with betamethasone dipropionate (BD) ointment or diflorasone diacetat …
[Comparative study of diflorasone diacetate and clobetasol-17-propionate in PUVA-resistant psoriasis].
Rozman TA, Wiedey KD, Renovanz HD. Rozman TA, et al. Z Hautkr. 1983 Mar 15;58(6):398-409. Z Hautkr. 1983. PMID: 6342288 Clinical Trial. German.
According to the physician's overall judgement, however, Clobetasol was favored significantly over Diflorasone-Diacetate, while the patients only showed a slight preference for Clobetasol. Based on these findings and previously published results, Diflorasone-Diaceta …
According to the physician's overall judgement, however, Clobetasol was favored significantly over Diflorasone-Diacetate, while the p …
21 results